Zoo Digital Group PLC
07 December 2004
ZOO Digital Group PLC ('the Company')
Exercise of Options
ZOO Digital Group plc announces that on 3 December 2004 it approved the issue
and allotment of 55,000 new ordinary shares in the capital of the Company
following an exercise of 55,000 share options under the Enterprise Management
Incentive Scheme at an exercise price of 2.75p per share.
These shares will rank pari passu with all existing ordinary shares.
Application has been made for admission of the new ordinary shares to trading on
the Alternative Investment Market of the London Stock Exchange and dealings are
expected to commence on 9 December 2004.
The ordinary shares referred to above are ordinary shares of 0.2 pence per
share. The number of shares in issue following admission is 279,637,830.
Enquiries:
Robert Deri, Chief Financial Officer
ZOO Digital Group plc Tel: 0114 241 3700
www.zoodigitalgroup.com
Alasdair Robinson
Noble & Company Limited Tel: 0131 225 9677
End
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.